Tower Research Capital LLC (Trc) Deciphera Pharmaceuticals, Inc. Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$13.58 - $17.36 $96,580 - $123,464	-7,112 Reduced 83.91%	1,364 $21,000
Q4 2023 Feb 13, 2024	BUY	$10.11 - $16.54 $73,348 - $119,997	7,255 Added 594.19%	8,476 $136,000
Q3 2023 Nov 14, 2023	SELL	$12.46 - $15.48 $69,726 - $86,626	-5,596 Reduced 82.09%	1,221 $15,000
Q2 2023 Aug 14, 2023	BUY	$13.28 - $15.96 $53,438 - $64,223	4,024 Added 144.07%	6,817 $95,000
Q1 2023 May 09, 2023	SELL	$14.26 - $22.1 $144,639 - $224,160	-10,143 Reduced 78.41%	2,793 $43,000
Q4 2022 Feb 10, 2023	BUY	$14.85 - $19.04 $26,759 - $34,310	1,802 Added 16.18%	12,936 $212,000
Q3 2022 Nov 10, 2022	SELL	$12.38 - $20.23 $29,018 - $47,419	-2,344 Reduced 17.39%	11,134 $206,000
Q2 2022 Aug 15, 2022	SELL	$9.11 - $13.98 $47,982 - $73,632	-5,267 Reduced 28.1%	13,478 $178,000
Q1 2022 May 12, 2022	SELL	$6.87 - $11.11 $9,143 - $14,787	-1,331 Reduced 6.63%	18,745 $174,000
Q4 2021 Feb 14, 2022	BUY	$7.7 - $37.13 $128,720 - $620,702	16,717 Added 497.68%	20,076 $196,000
Q3 2021 Nov 15, 2021	BUY	$26.46 - $37.15 $13,415 - $18,835	507 Added 17.78%	3,359 $114,000
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $61,957 - $90,769	-1,893 Reduced 39.89%	2,852 $105,000
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $71,530 - $100,468	1,771 Added 59.55%	4,745 $213,000
Q4 2020 Feb 16, 2021	BUY	$51.77 - $66.18 $47,524 - $60,753	918 Added 44.65%	2,974 $169,000
Q3 2020 Nov 16, 2020	SELL	$43.8 - $58.16 $12,088 - $16,052	-276 Reduced 11.84%	2,056 $105,000
Q2 2020 Aug 13, 2020	BUY	$37.05 - $65.03 $86,400 - $151,649	2,332 New	2,332 $139,000
Q1 2020 May 15, 2020	SELL	$33.63 - $69.4 $29,594 - $61,072	-880 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$31.7 - $69.93 $7,291 - $16,083	230 Added 35.38%	880 $55,000
Q3 2019 Nov 05, 2019	SELL	$19.95 - $38.85 $44,149 - $85,975	-2,213 Reduced 77.3%	650 $22,000
Q2 2019 Aug 13, 2019	BUY	$21.05 - $26.21 $60,266 - $75,039	2,863 New	2,863 $64,000
Q4 2018 Feb 14, 2019	SELL	$19.08 - $36.14 $973 - $1,843	-51 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$33.57 - $42.1 $1,712 - $2,147	51 New	51 $2,000
Q2 2018 Aug 15, 2018	SELL	$20.06 - $44.95 $35,265 - $79,022	-1,758 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$20.04 - $29.71 $26,292 - $38,979	1,312 Added 294.17%	1,758 $35,000
Q4 2017 Feb 09, 2018	BUY	$16.54 - $24.2 $7,376 - $10,793	446	446 $10,000

Others Institutions Holding DCPH

# of Institutions

Shares Held

293K

Call Options Held

500

Put Options Held

View Full List

About Deciphera Pharmaceuticals, Inc.

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

More about DCPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account